John Schmieg

1.6k total citations
28 papers, 1.4k citations indexed

About

John Schmieg is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, John Schmieg has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in John Schmieg's work include Immune Cell Function and Interaction (8 papers), Acute Myeloid Leukemia Research (4 papers) and Immunotherapy and Immune Responses (4 papers). John Schmieg is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Acute Myeloid Leukemia Research (4 papers) and Immunotherapy and Immune Responses (4 papers). John Schmieg collaborates with scholars based in United States, Spain and Japan. John Schmieg's co-authors include Moriya Tsuji, Richard W. Franck, Guangli Yang, Guangjie Yang, Gloria González‐Aseguinolaza, Yasuhiko Koezuka, Mitchell Kronenberg, Cornelia C. Bergmann, Masaru Taniguchi and James M. Wilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

John Schmieg

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Schmieg United States 10 861 422 347 162 95 28 1.4k
Sandra Ward United States 15 365 0.4× 168 0.4× 600 1.7× 56 0.3× 80 0.8× 23 1.2k
José J. Reina Spain 22 306 0.4× 497 1.2× 810 2.3× 41 0.3× 98 1.0× 40 1.3k
M.J. Miller United States 10 189 0.2× 142 0.3× 411 1.2× 60 0.4× 76 0.8× 16 1.0k
Frédéric Subra France 27 201 0.2× 291 0.7× 1.0k 3.0× 191 1.2× 190 2.0× 61 2.1k
Y. Yang China 7 318 0.4× 87 0.2× 358 1.0× 69 0.4× 101 1.1× 15 736
Milan Fábry Czechia 21 128 0.1× 164 0.4× 750 2.2× 184 1.1× 42 0.4× 82 1.3k
D. H. RICH United States 9 250 0.3× 161 0.4× 816 2.4× 289 1.8× 57 0.6× 11 1.2k
Niels‐Christian Reichardt Spain 23 311 0.4× 590 1.4× 1.4k 3.9× 33 0.2× 74 0.8× 55 1.6k
David B. Langley Australia 22 310 0.4× 65 0.2× 987 2.8× 126 0.8× 52 0.5× 46 1.6k
Valeri Metelev Russia 17 329 0.4× 70 0.2× 942 2.7× 211 1.3× 163 1.7× 51 1.4k

Countries citing papers authored by John Schmieg

Since Specialization
Citations

This map shows the geographic impact of John Schmieg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Schmieg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Schmieg more than expected).

Fields of papers citing papers by John Schmieg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Schmieg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Schmieg. The network helps show where John Schmieg may publish in the future.

Co-authorship network of co-authors of John Schmieg

This figure shows the co-authorship network connecting the top 25 collaborators of John Schmieg. A scholar is included among the top collaborators of John Schmieg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Schmieg. John Schmieg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Marks, Jennifer A., et al.. (2022). Extranodal NK/T-Cell Lymphoma, Nasal Type: A Case Series. 6(3). 1–5.
3.
Schmieg, John, et al.. (2022). A Rare Case of Monomorphic T-Cell Posttransplant Lymphoproliferative Disorder Presenting as Primary Cutaneous Anaplastic Large Cell Lymphoma, ALK Negative. American Journal of Dermatopathology. 44(11). e124–e126. 1 indexed citations
4.
Auerbach, Aaron, John Schmieg, & Nadine S. Aguilera. (2021). Pediatric Lymphoid and Histiocytic Lesions in the Head and Neck. Head and Neck Pathology. 15(1). 41–58. 7 indexed citations
5.
Soleimani, Arshia, Alba Navarro, Delong Liu, et al.. (2021). CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage. Leukemia & lymphoma. 63(4). 911–917. 2 indexed citations
6.
Quinn, Zachary L., et al.. (2019). Primary Dural Diffuse Large B-cell Lymphoma: A Comprehensive Review of Survival and Treatment Outcomes. Clinical Lymphoma Myeloma & Leukemia. 20(2). e105–e112. 6 indexed citations
8.
Schmieg, John, et al.. (2017). The Use of Smoothelin and Other Antibodies in the Diagnosis of Uterine and Soft Tissue Smooth Muscle Tumors. Applied immunohistochemistry & molecular morphology. 27(5). 386–391. 1 indexed citations
9.
Schmieg, John, et al.. (2016). A rare case of acute promyelocytic leukemia with focal bone marrow involvement presenting as a paraspinal myeloid sarcoma. Journal of Hematopathology. 9(4). 161–166. 2 indexed citations
10.
Schmieg, John, et al.. (2015). A Rare Case of Acute Promyelocytic Leukemia With Focal Bone Marrow Involvement Presenting as a Paraspinal Myeloid Sarcoma. American Journal of Clinical Pathology. 144(suppl 2). A113–A113.
11.
Zheng, Gang, et al.. (2012). Blastic Plasmacytoid Dendritic Cell Neoplasm: Cytopathologic Findings. Acta Cytologica. 56(2). 204–208. 7 indexed citations
12.
Schmieg, John, Guangli Yang, Richard W. Franck, & Moriya Tsuji. (2009). A Multifactorial Mechanism in the Superior Antimalarial Activity ofα-C-GalCer. SHILAP Revista de lepidopterología. 2010. 1–11. 11 indexed citations
13.
Chu, Eugene A., et al.. (2009). Pathology Quiz Case 1. Archives of Otolaryngology - Head and Neck Surgery. 135(8). 832–832. 1 indexed citations
14.
French, Roger H., Jerald Feldman, Weiming Qiu, et al.. (2007). Evaluation of Next Generation Fluids for ArF Immersion Lithography Beyond Water. Journal of Photopolymer Science and Technology. 20(5). 729–738. 7 indexed citations
15.
Yang, Guangjie, et al.. (2004). The C‐Glycoside Analogue of the Immunostimulant α‐Galactosylceramide (KRN7000): Synthesis and Striking Enhancement of Activity. Angewandte Chemie International Edition. 43(29). 3818–3822. 233 indexed citations
16.
Chen, Guangwu, John Schmieg, Moriya Tsuji, & Richard W. Franck. (2004). Efficient Synthesis of α-C-Galactosyl Ceramide Immunostimulants: Use of Ethylene-Promoted Olefin Cross-Metathesis. Organic Letters. 6(22). 4077–4080. 59 indexed citations
17.
Bruña–Romero, Oscar, John Schmieg, Margarita Del Val, Michael Buschle, & Moriya Tsuji. (2003). The Dendritic Cell-Specific Chemokine, Dendritic Cell-Derived CC Chemokine 1, Enhances Protective Cell-Mediated Immunity to Murine Malaria. The Journal of Immunology. 170(6). 3195–3203. 27 indexed citations
18.
Schmieg, John, Gloria González‐Aseguinolaza, & Moriya Tsuji. (2003). The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites. Microbes and Infection. 5(6). 499–506. 20 indexed citations
19.
González‐Aseguinolaza, Gloria, Luc Van Kaer, Cornelia C. Bergmann, et al.. (2002). Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines. The Journal of Experimental Medicine. 195(5). 617–624. 267 indexed citations
20.
Schmieg, John, et al.. (1998). Optical Photopolymers: Design and Applications. Advanced Materials. 10(15). 1219–1224. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026